The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells
Abstract
Sphingolipids are critical regulators of tumor microenvironments and play an important role in estrogen-dependent cancers. Estrogen and estrogen metabolites were found to be involved in prostate cancer. Fingolimod (FTY720) is a sphingokinase-1 (SphK1) inhibitor with anticancer properties against various tumor cell types. Herein, we investigated the interference of FTY720 with the cross talk between sphingolipid metabolism and estrogen metabolism within prostate cancer cells. FTY720 showed cytotoxic antiproliferative effects against androgen-dependent and -independent prostate cancer cells with IC50 ranging from 3.0 ± 0.3 to 6.8 ± 1.7 μM. Exposure of prostate cancer cells to FTY720 resulted in a dramatic decrease in the concentration of estradiol, estrone, 4-hydroxyestradiol and 16α-hydroxyestrone compared to control cells. However, FTY720 significantly increased the concentration of 2-methoxyestrone and 2-methoxyestradiol within prostate cancer cells. This was mirrored by significant downregulating of the expression of estrogen and catechol estrogen-synthesizing enzymes (CYP19, CYP1A1 and CYP1B1) within prostate cancer cells. On the other hand, FTY720 significantly upregulated the expression of catechol estrogen-detoxifying enzyme (COMT). Additionally, FTY720 abolished estrogen-stimulated expression of ERα and basal expression of ERβ within prostate cancer cells. Furthermore, FTY720 suppressed the expression of the ER-downstream regulated genes, CXCR4 and cyclin D1. Reciprocally, it was found that estradiol and catechol estrogens significantly induced the expression of SphK1 while methoxylated catechol estrogen suppressed its expression within prostate cancer cells in a dose-dependent manner. Current research has highlighted the hazardous influence of the estrogenic component to prostate cancer. We found that fingolimod (FTY720) could modulate the estrogenic micromilieu and interrupt its cross talk with sphingolipid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Minireview: Cyclin D1: Normal and Abnormal Functions
Fu, M., Wang, C., Li, Z., Sakamaki, T., & Pestell, R. G. (2004) · Endocrinology · doi:10.1210/en.2004-0959 · Cited by 966
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Chun, J., & Hartung, H.-P. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181cbf825 · Cited by 796
Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G. R., Firestone, G. L., & Leitman, D. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2446 · Cited by 576
Fabrication and Characteristics of Chitosan Sponge as a Tissue Engineering Scaffold
Ikeda, T., Ikeda, K., Yamamoto, K., Ishizaki, H., Yoshizawa, Y., Yanagiguchi, K., Yamada, S., & Hayashi, Y. (2014) · BioMed Research International · doi:10.1155/2014/786892 · Cited by 509
Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2
Takabe, K., Kim, R. H., Allegood, J. C., Mitra, P., Ramachandran, S., Nagahashi, M., Harikumar, K. B., Hait, N. C., Milstien, S., & Spiegel, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064162 · Cited by 266
Tissue physiology and pathology of aromatase
Stocco, C. (2012) · Steroids · doi:10.1016/j.steroids.2011.10.013 · Cited by 246
Estrogen action and prostate cancer
Nelles, J. L., Hu, W.-Y., & Prins, G. S. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.20 · Cited by 214
Castro-Rivera, E., Samudio, I., & Safe, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103339200 · Cited by 211
Watson, C., Long, J. S., Orange, C., Tannahill, C. L., Mallon, E., McGlynn, L. M., Pyne, S., Pyne, N. J., & Edwards, J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100220 · Cited by 172
Pchejetski, D., Böhler, T., Brizuela, L., Sauer, L., Doumerc, N., Golzio, M., Salunkhe, V. A., Teissié, J., Malavaud, B. A., Waxman, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1388 · Cited by 150
Cited by
Zaghloul, E., Handousa, H., Singab, A. N. B., Elmazar, M. M., Ayoub, I. M., & Swilam, N. (2023) · Plants · doi:10.3390/plants12010206 · Cited by 11
Metadata
- Authors
- Allam, R. M., Al-Abd, A. M., Khedr, A., Sharaf, O. A., Nofal, S. M., Khalifa, A. E., Mosli, H. A., & Abdel-Naim, A. B.
- Venue
- Toxicology Letters
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 291
- Pages
- 77-85
- ISSN
- 0378-4274 (ISSN-L)
- OpenAlex
- W2797369678
- Cited by
- 259
- References
- 39
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. https://app.cochat.ai/papers/10.1016/j.toxlet.2018.04.008
- The paper
- Allam, R. M., Al-Abd, A. M., Khedr, A., Sharaf, O. A., Nofal, S. M., Khalifa, A. E., Mosli, H. A., & Abdel-Naim, A. B. (2018). Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells. Toxicology Letters. https://doi.org/10.1016/j.toxlet.2018.04.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.